Clinical research progress of novel biologics for the treatment of lupus nephritis
Crossref DOI link: https://doi.org/10.1007/s10238-023-01143-9
Published Online: 2023-07-22
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Cui, Wenyan
Tian, Yunfei
Huang, Guangliang
Zhang, Xinhui
Li, Feigao
Liu, Xiuju
Text and Data Mining valid from 2023-07-22
Version of Record valid from 2023-07-22
Article History
Received: 6 April 2023
Accepted: 12 July 2023
First Online: 22 July 2023
Declarations
:
: The authors declare that there is no conflict of interest.